首页> 外文期刊>Electronic Physician >A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women
【24h】

A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women

机译:抑制素A检测对孕妇子痫前期的诊断价值研究

获取原文
           

摘要

Background Hypertensive disorders are common during pregnancy, and are among 3 important causes of maternal death. Preeclampsia occurs in 3 to 5% of pregnancies. Early diagnosis of this disorder can lead to better pregnancy outcomes. Objective The aim of this study was to determine the relationship between inhibin A serum levels during second stage pregnancy screening tests, and incidence and severity of preeclampsia. Methods In this study, 300 pregnant women who referred to Kowsar Hospital and carried out second stage pregnancy screening tests from September 2014 to March 2015 in Urmia city, Iran, were enrolled. Five ml venous blood samples were obtained from each participant, and inhibin A serum levels were evaluated in all cases. Finally, all the necessary information was obtained from the pregnancy files of participants after delivery, and gathered in a questionnaire. The data were analyzed using SPSS software version 18 and independent t-test, ANOVA and descriptive statistics were used. P-values less than 0.05 were considered significant. Results Among the 300 pregnant women who were studied, the gestational age at the time of acquiring blood samples was as follows: 169 cases (56.3%) at 16–17 weeks, 77 cases (25.7%) at 18–19 weeks and 14 cases at 20 weeks (4.7%). In this study, MOM of inhibin A was more than 1.25 in 12 cases that finally, preeclampsia occurred in them. This relationship was statistically significant (p=0.001). The relationship between MOM of inhibin A and severe preeclampsia was evaluated, and the relationship was significant (p=0.004). The relationship between MOM of inhibin A and pregnancy hypertension was not significant (p=0.643). Conclusion Considering the results of this study, we can conclude that MOM of inhibin A levels in maternal serum during second stage pregnancy screening tests can predict incidence and severity of developing preeclampsia in pregnant women. This is not true in cases of pregnancy hypertension.
机译:背景高血压疾病在怀孕期间很常见,并且是孕产妇死亡的三个重要原因之一。先兆子痫发生在3%至5%的孕妇中。对该疾病的早期诊断可导致更好的妊娠结局。目的本研究旨在确定第二阶段妊娠筛查试验中抑制素A的血清水平与先兆子痫的发生率和严重程度之间的关系。方法这项研究纳入了2014年9月至2015年3月在伊朗乌尔米亚市接受Kowsar医院并进行第二阶段妊娠筛查测试的300名孕妇。从每个参与者获得5ml静脉血样品,并在所有情况下评估抑制素A血清水平。最后,在分娩后从参与者的怀孕档案中获得所有必要的信息,并将其收集在问卷中。使用SPSS 18版软件分析数据,并使用独立t检验,方差分析和描述性统计数据。小于0.05的P值被认为是重要的。结果在接受研究的300名孕妇中,采集血样时的胎龄如下:16-17周时169例(56.3%),18-19周时77例(25.7%)和14例在20周时(4.7%)。在这项研究中,在最终发生子痫前期的12例患者中,抑制素A的MOM大于1.25。这种关系具有统计学意义(p = 0.001)。评价了抑制素A的MOM与严重子痫前期的关系,并且该关系具有显着性(p = 0.004)。抑制素A的MOM与妊娠高血压之间的关系不显着(p = 0.643)。结论根据这项研究的结果,我们可以得出结论,在第二阶段妊娠筛查测试中,孕妇血清中抑制素A水平的MOM可以预测孕妇先兆子痫的发生率和严重程度。在妊娠高血压病例中并非如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号